Suppr超能文献

非肿瘤性碘化钠转运体活性及术前甲状腺特征对甲状腺癌患者缓解过程的预测作用

Predictive role of nontumoral sodium iodide symporter activity and preoperative thyroid characteristics in remission process of thyroid cancer patients.

作者信息

Yildirim-Poyraz Nilufer, Yazgan Aylin, Ozdemir Elif, Gozalan Aysegul, Keskin Mutlay, Ersoy Reyhan, Turkolmez Seyda, Cakir Bekir

机构信息

Department of Nuclear Medicine, Ankara Ataturk Research and Training Hospital, Bilkent No:2, Ankara, Turkey,

出版信息

Ann Nucl Med. 2014 Aug;28(7):623-31. doi: 10.1007/s12149-014-0854-5. Epub 2014 May 14.

Abstract

OBJECTIVE

The target of radioiodine ablation therapy (RIAT) after complete tumor removal is the nontumoral remnant tissue. We aimed to evaluate sodium iodide symporter (NIS) expression in nontumoral thyroid tissue in differentiated thyroid cancer (DTC) patients who have complete but delayed structural response (DSR) to RIAT after surgery. Preoperative thyroid characteristics such as volume and nontumoral histology were also investigated for both DSR and its control group as potential predictors of insufficient NIS activity in this study.

METHODS

Total of 600 patients with postoperative remnant thyroid tissue and who were in remission after RIAT spontaneously, were included in the study. Patients with positive diagnostic whole body scan (DxWBS) with thyroid bed uptake and stimulated serum Tg level <2 ng/mL at first year visit after initial therapy were defined as DSR group. Immunohistochemical staining of NIS protein was performed on the nontumoral tissue sections from surgery and semi quantified in terms of density and intensity. DSR and its control group were also compared in terms of NIS expression, radioiodine (RAI) uptake on post-therapy scan and preoperative thyroid characteristics.

RESULTS

When compared with the control group, the density and intensity of NIS expression as well as the intensity of RAI uptake were significantly lower in DSR group (p = 0.001). There were also significant differences between groups regarding preoperative thyroid characteristics; i.e. preoperative thyroid volumes were significantly higher and the presence of concurrent benign thyroid disease was significantly more common in DSR group (p = 0.035, p = 0.001). Hashimoto thyroiditis was 8.59 times higher (95% CI; 2.31-31.96) and multinodular goiter was 7.50 times higher (95% CI; 1.88-29.91) among DSR group when compared with the control group.

CONCLUSIONS

Our findings suggest that insufficient NIS activity in nontumoral thyroid tissue associates with DSR in DTC patients who have postoperative remnant tissue. Preoperative thyroid characteristics such as volume and concomitant benign thyroid disease may have an important role in predicting the complete response time to RIAT in these patients.

摘要

目的

在肿瘤完全切除后,放射性碘消融治疗(RIAT)的目标是非肿瘤残留组织。我们旨在评估分化型甲状腺癌(DTC)患者在手术后对RIAT有完全但延迟的结构反应(DSR)时,非肿瘤甲状腺组织中碘化钠转运体(NIS)的表达。本研究还调查了术前甲状腺特征,如体积和非肿瘤组织学,作为DSR及其对照组中NIS活性不足的潜在预测指标。

方法

共有600例术后残留甲状腺组织且RIAT后自发缓解的患者纳入本研究。在初始治疗后第一年随访时,诊断性全身扫描(DxWBS)甲状腺床摄取阳性且刺激后血清Tg水平<2 ng/mL的患者被定义为DSR组。对手术切除的非肿瘤组织切片进行NIS蛋白的免疫组织化学染色,并根据密度和强度进行半定量分析。还比较了DSR组及其对照组在NIS表达、治疗后扫描时的放射性碘(RAI)摄取以及术前甲状腺特征方面的差异。

结果

与对照组相比,DSR组中NIS表达的密度和强度以及RAI摄取的强度均显著降低(p = 0.001)。两组在术前甲状腺特征方面也存在显著差异;即DSR组的术前甲状腺体积显著更高,并发良性甲状腺疾病的情况显著更常见(p = 0.035,p = 0.001)。与对照组相比,DSR组中桥本甲状腺炎的发生率高8.59倍(95%CI;2.31 - 31.96),多结节性甲状腺肿的发生率高7.50倍(95%CI;1.88 - 29.91)。

结论

我们的研究结果表明,术后残留组织的DTC患者中非肿瘤甲状腺组织中NIS活性不足与DSR相关。术前甲状腺特征,如体积和并发的良性甲状腺疾病,可能在预测这些患者对RIAT的完全反应时间方面具有重要作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验